Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
Launch One Acquisition Corp. - Class A Ordinary Shares (LPAA)
Company Research
Source: GlobeNewswire
HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that data collected by research teams at Memorial Sloan Kettering Cancer Center (MSK) and Shaare Zedek Medical Center (SZMC) featuring the Company’s mitochondrial augmentation technology in myelodysplastic syndrome (MDS) will be presented at the 67th American Society of Hematology’s (ASH) Annual Meeting and Exposition on December 6-9, 2025 in Orlando, FL. The data will be featured in an oral presentation to be held on Saturday, Dec 6, 2PM ET (abs25-9123_abstract), as well as part of a workshop called, “Mitochondria and metabolism – clinical trials,” to be held Friday, Dec 5, 5:10PM ET. The oral presentation, to be presented by principal investigator Dr. Omar Abdel-Wahab, will outline the MSK team’s progress with Minovia’s mitochondrial augme
Show less
Read more
Impact Snapshot
Event Time:
LPAA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LPAA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LPAA alerts
High impacting Launch One Acquisition Corp. - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LPAA
News
- Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and ExpositionGlobeNewswire
- Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic SyndromeGlobeNewswire
- Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic SyndromeGlobeNewswire
- Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic SyndromeGlobeNewswire
- Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic SyndromeGlobeNewswire